DK0428313T3 - Pyrimidonderivater samt analoge til behandling af astma og visse hudlidelser - Google Patents

Pyrimidonderivater samt analoge til behandling af astma og visse hudlidelser

Info

Publication number
DK0428313T3
DK0428313T3 DK90312117.6T DK90312117T DK0428313T3 DK 0428313 T3 DK0428313 T3 DK 0428313T3 DK 90312117 T DK90312117 T DK 90312117T DK 0428313 T3 DK0428313 T3 DK 0428313T3
Authority
DK
Denmark
Prior art keywords
asthma
treatment
analogues
well
skin disorders
Prior art date
Application number
DK90312117.6T
Other languages
English (en)
Inventor
John B Cheng
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0428313T3 publication Critical patent/DK0428313T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK90312117.6T 1989-11-13 1990-11-06 Pyrimidonderivater samt analoge til behandling af astma og visse hudlidelser DK0428313T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1989/005221 WO1991007177A1 (en) 1989-11-13 1989-11-13 Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders

Publications (1)

Publication Number Publication Date
DK0428313T3 true DK0428313T3 (da) 1994-03-07

Family

ID=22215372

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90312117.6T DK0428313T3 (da) 1989-11-13 1990-11-06 Pyrimidonderivater samt analoge til behandling af astma og visse hudlidelser

Country Status (17)

Country Link
US (1) US5342842A (da)
EP (1) EP0428313B1 (da)
JP (2) JPH0662412B2 (da)
KR (1) KR930001832B1 (da)
AT (1) ATE101040T1 (da)
AU (1) AU627631B2 (da)
CA (1) CA2029704C (da)
DE (1) DE69006452T2 (da)
DK (1) DK0428313T3 (da)
HU (1) HU212311B (da)
IE (1) IE63472B1 (da)
IL (1) IL96260A (da)
MY (1) MY111474A (da)
NZ (1) NZ236038A (da)
PT (1) PT95854B (da)
WO (2) WO1991007177A1 (da)
ZA (1) ZA909043B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH31245A (en) * 1991-10-30 1998-06-18 Janssen Pharmaceutica Nv 1,3-Dihydro-2H-imidazoÄ4,5-BÜ-quinolin-2-one derivatives.
DK0672031T3 (da) * 1992-12-02 2003-06-10 Pfizer Catecholdiethere som selektive PDE IV-inhibitorer
US5814651A (en) * 1992-12-02 1998-09-29 Pfizer Inc. Catechol diethers as selective PDEIV inhibitors
US5482944A (en) * 1993-07-13 1996-01-09 Pfizer Inc. Pyrimidones and imidazolinones for treatment of shock
JP2818820B2 (ja) * 1993-11-26 1998-10-30 ファイザー・インク. 抗炎症剤としての3−アリール−2−イソオキサゾリン類
US5502072A (en) * 1993-11-26 1996-03-26 Pfizer Inc. Substituted oxindoles
AU684887B2 (en) * 1994-03-09 1998-01-08 Pfizer Inc. Isoxazoline compounds as inhibitors of TNF release
MX9603943A (es) * 1994-03-09 1997-04-30 Pfizer Compuestos de isoxazolina como inhibidores de 5-lipooxigenasa.
US5563143A (en) * 1994-09-21 1996-10-08 Pfizer Inc. Catechol diether compounds as inhibitors of TNF release
CA2258728C (en) 1996-06-19 2011-09-27 Rhone Poulenc Rorer Limited Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
WO1998008828A1 (en) * 1996-08-27 1998-03-05 Nikken Chemicals Co., Ltd. 2-phenylmorpholin-5-one derivatives and pharmaceutical composition comprising the same
CA2402384A1 (en) * 2000-03-16 2001-09-20 Inflazyme Pharmaceuticals Ltd. Benzylated pde4 inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2401446A1 (de) * 1973-01-16 1974-07-25 Voorhees Pharmazeutische zubereitungen zur linderung von hautproliferationserkrankungen
SU888821A3 (ru) * 1976-12-03 1981-12-07 Шеринг Аг (Инофирма) Способ получени 5-(замещенный фенил)-оксазолидинонов или их серусодержащих аналогов
DE3315797A1 (de) * 1983-04-30 1984-10-31 Beiersdorf Ag, 2000 Hamburg Substituierte phenyl-2-(1h)-pyrimidinone, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
GB8416140D0 (en) * 1984-06-25 1984-08-01 Fujisawa Pharmaceutical Co Pyrimidinone derivatives
HU215433B (hu) * 1986-04-29 2000-05-28 Pfizer Inc. Eljárás új 2-oxo-5-fenil-pirimidin-származékok előállítására

Also Published As

Publication number Publication date
WO1991007177A1 (en) 1991-05-30
JPH03209322A (ja) 1991-09-12
HUT70052A (en) 1995-09-28
AU6653690A (en) 1991-08-01
IL96260A0 (en) 1991-08-16
IE63472B1 (en) 1995-04-19
MY111474A (en) 2000-06-30
HU212311B (en) 1996-05-28
EP0428313A3 (en) 1991-11-06
EP0428313B1 (en) 1994-02-02
AU627631B2 (en) 1992-08-27
NZ236038A (en) 1997-03-24
IE904058A1 (en) 1991-05-22
IL96260A (en) 1995-11-27
CA2029704A1 (en) 1991-05-14
WO1991007178A1 (en) 1991-05-30
DE69006452T2 (de) 1994-05-11
HU9201575D0 (en) 1993-04-28
US5342842A (en) 1994-08-30
CA2029704C (en) 1995-02-07
EP0428313A2 (en) 1991-05-22
PT95854A (pt) 1991-09-13
DE69006452D1 (de) 1994-03-17
KR930001832B1 (ko) 1993-03-15
ZA909043B (en) 1992-06-24
JPH0748255A (ja) 1995-02-21
JP2514163B2 (ja) 1996-07-10
PT95854B (pt) 1997-11-28
JPH0662412B2 (ja) 1994-08-17
ATE101040T1 (de) 1994-02-15
KR910009259A (ko) 1991-06-28

Similar Documents

Publication Publication Date Title
DK0776324T3 (da) Endothelin-antagonister
PL292101A1 (en) Method of obtaining novel derivatives of cyclopentylpurine and cyclopentylpyrimidine
DK0565549T3 (da) Anvendelse af 1,3-oxathiolannucleosidanaloger til fremstilling af et præparat til behandling af hepatitis B
NO304946B1 (no) Xantinderivat samt dets anvendelse
PT674634E (pt) Processos para preparar 1,3-oxatiolanos substituidos com propriedades antivirais
FI102069B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten indolijohdannaisten valmistamiseksi
NO942452D0 (no) Amid- og ureaderivater med antihyperkolesteremisk aktivitet, deres fremstilling og terapeutiske anvendelser
GB9408185D0 (en) New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
AU627631B2 (en) Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders
AU2868689A (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
FI94354C (fi) Menetelmä farmaseuttisesti aktiivisten peptidien valmistamiseksi
NO872382L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
DK0617959T3 (da) Lægemiddel til behandling af hudsygdomme
IL84096A0 (en) Therapeutic agent for the treatment of peptic ulcer disease comprising a purine derivative
DK0855398T3 (da) Sesquiterpenderivater med antiviral aktivitet
DK215886D0 (da) 1,3-oxathianderivater
FI103885B (fi) Menetelmä terapeuttisesti aktiivisten 1-bentsyyli-4-fenyylipiperatsiinijohdannaisten valmistamiseksi ja välituotteina käyttökelpoisia yhdisteitä
IT1213219B (it) Derivati amminoalchilnaftalenici ad attivita' farmacologica.
DK0784973T3 (da) Quinoxalinderivater til behandling af tinnitus
RO93389A (ro) Procedeu pentru prepararea unor derivati de 4-fluortiolcarbanilida
GR3002699T3 (en) Process for stabilising procaterol